GSK plc GSK
Set alert
49.32 USD +0.18 +0.38%
As of Nov 3, 10:03 AM ET
49.19 Day range 49.57
45.81 52-week range 61.70
- YTD
- +0.56%
- 1 year
- +6.40%
- Open
- 49.41
- Prev close
- 49.13
- Mkt cap
- 98.88B
- Vol
- 312.19K
- Avg vol
- 4.05M
- EPS
- 2.87
- P/E
- 17.19
- Div yield
- 3.64%
More statistics
- Low
- 49.19
- High
- 49.57
- Forward P/E
- 9.91
- Beta
- 0.28
- Short ratio
- 2.86
- Inst. own
- 17.46%
- Dividend
- 1.82
- Ex-div date
- Aug 13, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 49.43
- 200-d avg
- 52.34
- 1y target
- 59.12
MAX chart
Events in this range
- Mar 5, 1993Dividend: 0.29125
- Mar 4, 1998Dividend: 0.6509
- Mar 3, 1999Dividend: 0.7517
- Mar 1, 2000Dividend: 0.7195
Signals (57)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Mar 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Jun 1, 2022 | 4 years ago |
| SMA: Bearish | Jun 1, 2022 | 4 years ago |
| MACD: Sell Signal | Jun 1, 2022 | 4 years ago |
| SMA: Bullish | Sep 1, 2021 | 5 years ago |
| MACD: Buy Signal | Sep 1, 2021 | 5 years ago |
| SMA: Bullish | Jun 1, 2021 | 5 years ago |
| MACD: Sell Signal | Sep 1, 2020 | 6 years ago |
| SMA: Bearish | Jun 1, 2020 | 6 years ago |
| SMA: Bearish | Dec 1, 2019 | 6 years ago |
| SMA: Bullish | Sep 1, 2019 | 7 years ago |
| SMA: Bullish | Jun 1, 2019 | 7 years ago |
| MACD: Buy Signal | Jun 1, 2019 | 7 years ago |
| SMA: Bearish | Mar 1, 2019 | 7 years ago |
| SMA: Bullish | Mar 1, 2018 | 8 years ago |
Newest 20 of 57.
Analyst view
Consensus: hold
Hold
Price target (mean) 59.12 +19.9% upside
Now 49.32
- Target (low)
- 49.00
- Target (mean)
- 59.12
- Target (high)
- 70.00
Ratings (0m) 9 3 buy · 5 hold · 1 sell
- Strong buy1
- Buy2
- Hold5
- Sell1
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.73676 | 0.72585 – 0.74766 | 0.69843 | +5.5% | 8.87B | +2.9% | 2 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 4.76 | 4.72 – 4.80 | 4.71 | +1.1% | 33.84B | +3.6% | 4 |
| Next year | 4.96 | 4.83 – 5.15 | 4.76 | +4.1% | 35.37B | +4.5% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jan 6, 2026 | Barclays | Downgrade | Equal-Weight | Underweight |
| Nov 12, 2024 | Jefferies | Downgrade | Buy | Hold |
| Oct 31, 2024 | Guggenheim | Downgrade | Buy | Neutral |
| Jul 8, 2024 | UBS | Downgrade | Buy | Neutral |
| Jul 2, 2024 | Jefferies | Maintained | Buy | Buy |
| May 30, 2024 | Goldman Sachs | Initiated | — | Neutral |
| Mar 4, 2024 | Guggenheim | Upgrade | Neutral | Buy |
| Jan 23, 2024 | Morgan Stanley | Initiated | — | Equal-Weight |
| Jan 3, 2024 | Jefferies | Upgrade | Hold | Buy |